| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Chemical Biology as a Driver of Innovation in Cancer Research and Drug Discovery
|
Kostic, Milka
|
|
2017
|
24 |
9 |
p. 1057-
1 p.
|
article
|
| 2 |
Drug Discovery and Chemical Biology of Cancer Epigenetics
|
Ribich, Scott
|
|
2017
|
24 |
9 |
p. 1120-1147
28 p.
|
article
|
| 3 |
Emerging Opportunities for Target Discovery in Rare Cancers
|
Sharifnia, Tanaz
|
|
2017
|
24 |
9 |
p. 1075-1091
17 p.
|
article
|
| 4 |
Joining Forces: The Chemical Biology–Medicinal Chemistry Continuum
|
Plowright, Alleyn T.
|
|
2017
|
24 |
9 |
p. 1058-1065
8 p.
|
article
|
| 5 |
Small-Molecule Inhibitors Targeting DNA Repair and DNA Repair Deficiency in Research and Cancer Therapy
|
Hengel, Sarah R.
|
|
2017
|
24 |
9 |
p. 1101-1119
19 p.
|
article
|
| 6 |
Small-Molecule Targets in Immuno-Oncology
|
Dhanak, Dashyant
|
|
2017
|
24 |
9 |
p. 1148-1160
13 p.
|
article
|
| 7 |
Targeted Protein Degradation: from Chemical Biology to Drug Discovery
|
Cromm, Philipp M.
|
|
2017
|
24 |
9 |
p. 1181-1190
10 p.
|
article
|
| 8 |
Targeting Metabolism for Cancer Therapy
|
Luengo, Alba
|
|
2017
|
24 |
9 |
p. 1161-1180
20 p.
|
article
|
| 9 |
The Pursuit of Therapeutic Biomarkers with High-Throughput Cancer Cell Drug Screens
|
Williams, Steven P.
|
|
2017
|
24 |
9 |
p. 1066-1074
9 p.
|
article
|
| 10 |
Tumor Organoids as a Pre-clinical Cancer Model for Drug Discovery
|
Weeber, Fleur
|
|
2017
|
24 |
9 |
p. 1092-1100
9 p.
|
article
|
Journal description